Shopping Cart

Your shopping cart is currently empty

About us

TargetMol Chemicals. Inc is a global life science technology company committed to advancing biomedical research and accelerating drug discovery innovation. Headquartered in Boston, Massachusetts, USA, the company provides scientists worldwide with high-quality research reagents, bioactive compounds, and integrated discovery solutions designed to support cutting-edge scientific research.TargetMol was honored with the CiteAb “Biochemical Supplier to Watch” Award in 2023 and the Bioz “Rising Star” Award in the inhibitor product category in 2025, reflecting strong international recognition from research institutions and scientific partners worldwide.

Products & Services

300+

300+ Compound Libraries

100K+

100,000+ Inhibitors & Agonist

24K+

24,000+ Natural Products

Driven by scientific rigor and innovation, TargetMol has established a comprehensive product portfolio covering small-molecule inhibitors and agonists, compound libraries, natural products, recombinant proteins, antibodies, peptides, and life science assay kits. With over 100,000 bioactive compounds, 24,000+ natural products, 14,500+ recombinant proteins, and 26,000+ antibodies, TargetMol supports cutting-edge research across oncology, immunology, neuroscience, metabolism, epigenetics, and translational medicine.

14,500+ Recombinant Proteins

Technical Services

Reagent Kits

To further empower drug discovery and mechanism research, TargetMol has built an integrated R&D platform in Shanghai featuring CADD & AIDD technologies, pharmacology laboratories, and medicinal chemistry capabilities. Through more than 300 specialized technical services—including virtual screening, molecular interaction analysis, compound activity evaluation, and lead optimization. TargetMol delivers efficient and flexible solutions tailored to the evolving needs of modern biomedical research.

Industry recognition

Today, TargetMol products and services are trusted by leading academic institutions and research organizations worldwide, including Harvard University, Weill Cornell Medicine, Tsinghua University, Peking University, FDA, NIH, and the Chinese Academy of Medical Sciences. TargetMol products have been cited in over 10,000 scientific publications, including Nature, Science, and Cell.

Recognized for its growing impact in the global life science community, TargetMol received the CiteAb “Supplier to watch out for” award in 2023 and Bioz "Rising Star" award in inhibitor product catagory in 2025. These recognitions reflect the company’s commitment to quality, innovation, and scientific excellence.

At TargetMol, we are committed to empowering discovery, advancing translational science, and enabling researchers worldwide to accelerate the development of next-generation therapeutics.